Corporate GovernanceApr 27, 2026, 05:16 PM
OVID to Hold 2026 Annual Meeting; Board Size Reduced to 6
AI Summary
Ovid Therapeutics Inc. will hold its 2026 Annual Meeting of Stockholders virtually on June 10, 2026, with a record date of April 15, 2026. Stockholders will vote on the election of one Class III director nominee, an advisory resolution on executive compensation, and the ratification of KPMG LLP as the independent auditor for 2026. The Board has approved a reduction in its size from seven to six directors, effective at the Annual Meeting, as Dr. Bernstein will not stand for reelection. Margaret Alexander was appointed President and CEO in January 2026.
Key Highlights
- 2026 Annual Meeting to be held virtually on June 10, 2026.
- Record date for voting is April 15, 2026.
- Board size to be reduced from 7 to 6 directors.
- Dr. Bernstein will not stand for reelection as Class III director.
- Jeremy M. Levin nominated for reelection as Class III director.
- Stockholders to vote on advisory executive compensation.
- KPMG LLP to be ratified as independent auditor for 2026.
- 173,037,131 shares outstanding and entitled to vote as of April 15, 2026.